Lobbying

Sellers, Dorsey & Associates's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $120K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.

Sellers, Dorsey & Associates

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$120K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Sellers, Dorsey & Associates lobbying by quarter
Sellers, Dorsey & Associates lobbying by quarter
QuarterAmountReports
Q4 2022$40K1
Q1 2023$40K1
Q2 2023$40K1
Q3 2023$40K1
Q4 2023$40K1
Q1 2024$40K1
Q2 2024$40K1
Q3 2024$40K1
Q4 2024$40K1
Q1 2025$40K1
Q2 2025$40K1
Q3 2025$40K1
Q4 2025$40K1
Q1 2026$40K1
Q2 2026$40K1
Q3 2026$00

By issue

  • Medicare and Medicaid$40K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES1 reports
  • SENATE1 reports

Firms it paid

Firm
Mehlman Consulting$600K15 quarters

Former officials lobbying for it

Former position
CAITLIN VAN SANTSr Pol Adv, Leg Dir, Interim COS (Rep. Butterfield)Q4 2022
LISA GOLDMANSr Counsel, House Comm on Energy & Commerce; Chief Counsel, Sr Counsel (E&C Subcommittee on Consumer Protection & Commerce); Counsel House Comm on E&CQ4 2022

Lobbying reports

Filed by
07/17for Q2Mehlman Consulting$40K
04/17for Q1Mehlman Consulting$40K
01/16for Q4 2025Mehlman Consulting$40K
25/10/17for Q3 2025Mehlman Consulting$40K
25/07/18for Q2 2025Mehlman Consulting$40K
25/04/17for Q1 2025Mehlman Consulting$40K
25/01/20for Q4 2024Mehlman Consulting$40K
24/10/18for Q3 2024Mehlman Consulting$40K
24/07/18for Q2 2024Mehlman Consulting$40K
24/04/19for Q1 2024Mehlman Consulting$40K
24/01/19for Q4 2023Mehlman Consulting$40K
23/10/19for Q3 2023Mehlman Consulting$40K
23/07/18for Q2 2023Mehlman Consulting$40K
23/04/19for Q1 2023Mehlman Consulting$40K
23/01/19for Q4 2022Mehlman Consulting$40K